Nephrogen

📍 New York, United States🗓 Founded 2022👥 5 employees💰 Last funded Jul 2025
Biotechnology Research🌐 nephrogenbiotech.com
Website LinkedIn
Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nephrogen?
Nephrogen has 1 investors on record on gritt.io, 1 mid-stage.
When did Nephrogen last raise funding?
The most recent investment in Nephrogen recorded on gritt.io was in July 2025.
When was Nephrogen founded?
Nephrogen was founded in 2022.
What industry is Nephrogen in?
Nephrogen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nephrogen based?
Nephrogen is headquartered in New York, United States.